Agneta von Gegerfelt

1.4k total citations
20 papers, 1.1k citations indexed

About

Agneta von Gegerfelt is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, Agneta von Gegerfelt has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Virology, 13 papers in Immunology and 7 papers in Infectious Diseases. Recurrent topics in Agneta von Gegerfelt's work include HIV Research and Treatment (13 papers), Immunotherapy and Immune Responses (7 papers) and Immune Cell Function and Interaction (6 papers). Agneta von Gegerfelt is often cited by papers focused on HIV Research and Treatment (13 papers), Immunotherapy and Immune Responses (7 papers) and Immune Cell Function and Interaction (6 papers). Agneta von Gegerfelt collaborates with scholars based in United States, Sweden and France. Agneta von Gegerfelt's co-authors include E M Fenyö, Jan Albert, Francesca Chiodi, Eric Olausson, Linda Morfeldt-Månson, Birgitta Åsjö, Barbara K. Felber, George N. Pavlakis, Kristina Broliden and Candido Alicea and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and PLoS ONE.

In The Last Decade

Agneta von Gegerfelt

20 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Agneta von Gegerfelt United States 16 844 523 470 273 176 20 1.1k
Innocent Mboudjeka United States 18 749 0.9× 371 0.7× 402 0.9× 252 0.9× 269 1.5× 22 1.0k
Zimra R. Israel United States 16 539 0.6× 489 0.9× 236 0.5× 304 1.1× 206 1.2× 21 888
Jan zur Megede United States 19 587 0.7× 557 1.1× 359 0.8× 302 1.1× 377 2.1× 32 1.1k
Brent Welcher United States 11 560 0.7× 498 1.0× 475 1.0× 263 1.0× 225 1.3× 12 1.0k
Ines Frank United States 15 998 1.2× 863 1.7× 321 0.7× 306 1.1× 162 0.9× 31 1.3k
Bruce Travis United States 16 896 1.1× 391 0.7× 390 0.8× 355 1.3× 285 1.6× 17 1.1k
Calvin B. Carpenter United States 4 917 1.1× 590 1.1× 320 0.7× 267 1.0× 252 1.4× 5 1.1k
Georgia R. Krivulka United States 11 776 0.9× 644 1.2× 283 0.6× 256 0.9× 297 1.7× 11 1.0k
Louisa Tao United Kingdom 15 693 0.8× 703 1.3× 176 0.4× 344 1.3× 190 1.1× 21 1.1k
Peter Silvera United States 23 1.3k 1.6× 700 1.3× 373 0.8× 700 2.6× 544 3.1× 38 1.6k

Countries citing papers authored by Agneta von Gegerfelt

Since Specialization
Citations

This map shows the geographic impact of Agneta von Gegerfelt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agneta von Gegerfelt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agneta von Gegerfelt more than expected).

Fields of papers citing papers by Agneta von Gegerfelt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agneta von Gegerfelt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agneta von Gegerfelt. The network helps show where Agneta von Gegerfelt may publish in the future.

Co-authorship network of co-authors of Agneta von Gegerfelt

This figure shows the co-authorship network connecting the top 25 collaborators of Agneta von Gegerfelt. A scholar is included among the top collaborators of Agneta von Gegerfelt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Agneta von Gegerfelt. Agneta von Gegerfelt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bekerman, Elena, Joseph Hesselgesser, Brian Carr, et al.. (2019). PD-1 Blockade and TLR7 Activation Lack Therapeutic Benefit in Chronic Simian Immunodeficiency Virus-Infected Macaques on Antiretroviral Therapy. Antimicrobial Agents and Chemotherapy. 63(11). 43 indexed citations
2.
Khatri, Vishal, et al.. (2018). Prospects of developing a prophylactic vaccine against human lymphatic filariasis – evaluation of protection in non-human primates. International Journal for Parasitology. 48(9-10). 773–783. 23 indexed citations
3.
Dakshinamoorthy, Gajalakshmi, Agneta von Gegerfelt, Hanné Andersen, Mark G. Lewis, & Ramaswamy Kalyanasundaram. (2014). Evaluation of a Multivalent Vaccine against Lymphatic Filariasis in Rhesus macaque Model. PLoS ONE. 9(11). e112982–e112982. 20 indexed citations
4.
Siddappa, Nagadenahalli B., Victor G. Kramer, Sandra J. Lee, et al.. (2013). Live Attenuated Rev-Independent Nef¯SIV Enhances Acquisition of Heterologous SIVsmE660 in Acutely Vaccinated Rhesus Macaques. PLoS ONE. 8(9). e75556–e75556. 7 indexed citations
5.
Jalah, Rashmi, Vainav Patel, Viraj Kulkarni, et al.. (2012). IL-12 DNA as molecular vaccine adjuvant increases the cytotoxic T cell responses and breadth of humoral immune responses in SIV DNA vaccinated macaques. Human Vaccines & Immunotherapeutics. 8(11). 1620–1629. 54 indexed citations
6.
Kulkarni, Viraj, Rashmi Jalah, Brunda Ganneru, et al.. (2010). Comparison of immune responses generated by optimized DNA vaccination against SIV antigens in mice and macaques. Vaccine. 29(39). 6742–6754. 20 indexed citations
7.
Valentin, Antonio, Agneta von Gegerfelt, Margherita Rosati, et al.. (2010). Repeated DNA therapeutic vaccination of chronically SIV-infected macaques provides additional virological benefit. Vaccine. 28(8). 1962–1974. 29 indexed citations
8.
9.
Valentin, Antonio, Agneta von Gegerfelt, Rashmi Jalah, et al.. (2009). P18-09. Persistent virological benefit in SIV-infected macaques upon therapeutic vaccination upon vaccination with DNA vectors. Retrovirology. 6(S3). 1 indexed citations
10.
Rosati, Margherita, Antonio Valentin, Rashmi Jalah, et al.. (2008). Increased immune responses in rhesus macaques by DNA vaccination combined with electroporation. Vaccine. 26(40). 5223–5229. 73 indexed citations
11.
Smulevitch, Sergey, Jenifer Bear, Candido Alicea, et al.. (2006). RTE and CTE mRNA export elements synergistically increase expression of unstable, Rev-dependent HIV and SIV mRNAs. Retrovirology. 3(1). 6–6. 21 indexed citations
12.
Felber, Barbara K., Agneta von Gegerfelt, Antonio Valentin, et al.. (2006). Preservation of a subset of SIV-specific central memory CD4+ T cells correlates with control of viremia in SIVmac251 infected macaques. Retrovirology. 3(S1). 1 indexed citations
13.
Rosati, Margherita, Agneta von Gegerfelt, Patricia Roth, et al.. (2005). DNA Vaccines Expressing Different Forms of Simian Immunodeficiency Virus Antigens Decrease Viremia upon SIVmac251 Challenge. Journal of Virology. 79(13). 8480–8492. 73 indexed citations
14.
Hel, Zdeněk, Wen-Po Tsai, Arthur Thornton, et al.. (2001). Potentiation of Simian Immunodeficiency Virus (SIV)-Specific CD4+ and CD8+ T Cell Responses by a DNA-SIV and NYVAC-SIV Prime/Boost Regimen. The Journal of Immunology. 167(12). 7180–7191. 74 indexed citations
15.
16.
Gegerfelt, Agneta von, Charlotta Nilsson, Per Putkonen, & Kristina Broliden. (1994). Broadly reactive HIV-2 and SIVmac specific antibody-dependent cellular cytotoxicity in immunized and infected cynomolgus monkeys. Vaccine. 12(13). 1203–1208. 6 indexed citations
17.
Björling, Ewa, Gabriella Scarlatti, Agneta von Gegerfelt, et al.. (1993). Autologous Neutralizing Antibodies Prevail in HIV-2 but Not in HIV-1 Infection. Virology. 193(1). 528–530. 69 indexed citations
18.
Broliden, P A, Agneta von Gegerfelt, J Rosen, et al.. (1992). Identification of human neutralization-inducing regions of the human immunodeficiency virus type 1 envelope glycoproteins.. Proceedings of the National Academy of Sciences. 89(2). 461–465. 102 indexed citations
19.
Gegerfelt, Agneta von, et al.. (1991). Isolate-specific neutralizing antibodies in patients with progressive HIV-1-related disease. Virology. 185(1). 162–168. 57 indexed citations
20.
Fenyö, E M, Linda Morfeldt-Månson, Francesca Chiodi, et al.. (1988). Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. Journal of Virology. 62(11). 4414–4419. 378 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Innocent Mboudjeka Breakdown of academic impact, for papers by Zimra R. Israel Breakdown of academic impact, for papers by Jan zur Megede Breakdown of academic impact, for papers by Brent Welcher Breakdown of academic impact, for papers by Ines Frank Breakdown of academic impact, for papers by Bruce Travis Breakdown of academic impact, for papers by Calvin B. Carpenter Breakdown of academic impact, for papers by Georgia R. Krivulka Breakdown of academic impact, for papers by Louisa Tao Breakdown of academic impact, for papers by Peter Silvera
Rankless by CCL
2026